Search results
Jump to navigation
Jump to search
Page title matches
- Name = Lymphoma | ...xes 1975-2000.jpg|right|350px|5-Year Relative Survival Rates By Year Dx By Lymphoma type All Ages, All Races, Both Sexes 1975-2000.}}1 KB (150 words) - 14:58, 1 January 2009
- 12 bytes (1 word) - 17:11, 18 November 2007
- 78 bytes (10 words) - 15:53, 13 December 2008
- Auto-populated based on [[Special:WhatLinksHere/Lymphoma]]. Needs checking by a human.647 bytes (82 words) - 18:12, 11 January 2010
- ...syndrome]]; [[lymphomatoid papulosis]]; and [[primary cutaneous anaplastic lymphoma]] are the best characterized of these disorders."<ref>{{MeSH}}</ref>869 bytes (106 words) - 11:48, 6 September 2009
- 204 bytes (27 words) - 11:51, 6 September 2009
- Auto-populated based on [[Special:WhatLinksHere/Cutaneous T cell lymphoma]]. Needs checking by a human.444 bytes (57 words) - 15:47, 11 January 2010
- {{r|Lymphoma}}252 bytes (37 words) - 17:24, 21 March 2024
- 402 bytes (54 words) - 20:02, 1 July 2010
- 81 bytes (10 words) - 20:02, 1 July 2010
Page text matches
- Name = Lymphoma | ...xes 1975-2000.jpg|right|350px|5-Year Relative Survival Rates By Year Dx By Lymphoma type All Ages, All Races, Both Sexes 1975-2000.}}1 KB (150 words) - 14:58, 1 January 2009
- {{r|Lymphoma}} {{r|Diffuse large B-Cell lymphoma||**}}453 bytes (58 words) - 16:50, 18 June 2010
- {{r|B-cell lymphoma}} {{r|Hodgkin's lymphoma}}770 bytes (94 words) - 23:36, 30 June 2010
- A [[medication]] and [[immunosuppressive agent]] used to treat [[lymphoma]] and [[leukemia]].129 bytes (14 words) - 15:43, 5 April 2009
- ...syndrome]]; [[lymphomatoid papulosis]]; and [[primary cutaneous anaplastic lymphoma]] are the best characterized of these disorders."<ref>{{MeSH}}</ref>869 bytes (106 words) - 11:48, 6 September 2009
- ...m infectious mononucleosis (IM), to nasal-pharyngeal cancer, and Burkitt's lymphoma.204 bytes (26 words) - 09:16, 5 September 2009
- ...trosourea, a nitrosourea-derived alkylating agent used in the therapy of [[lymphoma]]s and [[glioma]]s; administered both intravenously and as a surgically imp257 bytes (33 words) - 16:46, 18 June 2010
- ...ic agent]], principally used for [[Hodgkin's disease]] and [[non-Hodgkin's lymphoma]], of the family of [[nitrogen mustards]] in the class of [[alkylating agen217 bytes (26 words) - 15:59, 5 February 2009
- | [[Anaplastic lymphoma kinase]] || [[Crizotinib]] || Anaplastic large-cell lymphoma<br/>ALK-positive non-small cell [[lung cancer|lung carcinoma]] (NSCLC)1 KB (171 words) - 09:06, 9 September 2020
- ...cancer]], [[head and neck cancer]], [[testicular cancer]], [[non-Hodgkin's lymphoma]], [[penile carcinoma]], pleural malignant effusions, [[squamous cell carci ...y Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin’s Lymphoma3 KB (363 words) - 19:07, 1 July 2010
- ...ered anti-[[CD20 antigen|CD20]] [[antibody]] for the treatment of B-cell [[lymphoma]]."<ref>{{MeSH}}</ref>257 bytes (31 words) - 01:39, 7 October 2013
- {{r|Lymphoma}}220 bytes (33 words) - 23:48, 1 July 2010
- {{r|Lymphoma}}252 bytes (37 words) - 17:24, 21 March 2024
- ...odgkin's lymphoma following R-CHOP and pegylated filgrastim |journal=Leuk. Lymphoma |volume=46 |issue=10 |pages=1523–6 |year=2005 |pmid=16194900 |doi=10.10802 KB (308 words) - 17:34, 10 February 2024
- Its primary indications are for [[Hodgkin's disease]] and [[non-Hodgkin's lymphoma]]. Mechlorethamine is toxic to the bone marrow and gastrointestinal system.670 bytes (83 words) - 20:14, 1 July 2010
- {{r|T-cell lymphoma}}483 bytes (68 words) - 22:43, 7 June 2009
- {{rpl|Lymphoma}}374 bytes (41 words) - 12:15, 17 May 2023
- ...to form the active aldophosphamide. It has been used in the treatment of [[lymphoma]] and [[leukemia]]. Its side effect, alopecia, has been used for defleecing557 bytes (72 words) - 03:02, 7 October 2013
- Auto-populated based on [[Special:WhatLinksHere/Cutaneous T cell lymphoma]]. Needs checking by a human.444 bytes (57 words) - 15:47, 11 January 2010
- {{r|Lymphoma}}670 bytes (82 words) - 14:13, 19 June 2010